INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Grant or awardVerified data

Yang Watkin Phoebe L. reported GEHC

Director · GE HealthCare Technologies Inc. · Common Stock, par value $0.01 per share

Side
A
Value
—
Shares
3,586
Price
—
Executed
May 7, 2026
Disclosed
May 11, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
May 7 executedMay 11, 2026 disclosed

GEHC · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
17/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+9 / 25

No reported dollar value · 39.3% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · GEHC

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    EC
    Estrampes CatherineChief Commer. & Growth Officer
    GEHCGE HealthCare Technologies Inc.
    Tax withholding
    		F$36K
    508 sh
    		Sep 3, 2026Sep 4, 2026
    traded Sep 3, 2026
    		+1dSEC FORM 4

    Evidence

    9
    HY
    Holton Adam YChief People Officer
    GEHCGE HealthCare Technologies Inc.
    Tax withholding
    		F$47K
    673 sh
    		Sep 3, 2026Sep 4, 2026
    traded Sep 3, 2026
    		+1dSEC FORM 4

    Evidence

    12
    OM
    O'Neill Kevin MichaelCEO, PDx
    GEHCGE HealthCare Technologies Inc.
    Tax withholding
    		F$51K
    718 sh
    		Sep 3, 2026Sep 4, 2026
    traded Sep 3, 2026
    		+1dSEC FORM 4

    Evidence

    9
    NA
    Newcomb George A.Chief Accounting Officer
    GEHCGE HealthCare Technologies Inc.
    Tax withholding
    		F$7,903
    112 sh
    		Sep 3, 2026Sep 4, 2026
    traded Sep 3, 2026
    		+1dSEC FORM 4

    Evidence

    12
    KT
    Kass-Hout TahaChief Technology Officer
    GEHCGE HealthCare Technologies Inc.
    Tax withholding
    		F$106K
    1,502 sh
    		Sep 3, 2026Sep 4, 2026
    traded Sep 3, 2026
    		+1dSEC FORM 4

    Evidence

    12
    RP
    Rackliffe PhilipCEO, AIS
    GEHCGE HealthCare Technologies Inc.
    Tax withholding
    		F$56K
    798 sh
    		Sep 3, 2026Sep 4, 2026
    traded Sep 3, 2026
    		+1dSEC FORM 4

    Evidence

    9
    RP
    Rackliffe PhilipCEO, AIS
    GEHCGE HealthCare Technologies Inc.
    Tax withholding
    		F$24K
    340 sh
    		Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    		+2dSEC FORM 4

    Evidence

    9
    RP
    Rackliffe PhilipCEO, AIS
    GEHCGE HealthCare Technologies Inc.
    Tax withholding
    		F$21K
    290 sh
    		Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    		+2dSEC FORM 4

    Evidence

    9
    RP
    Rackliffe PhilipCEO, AIS
    GEHCGE HealthCare Technologies Inc.
    Tax withholding
    		F$16K
    226 sh
    		Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    		+2dSEC FORM 4

    Evidence

    21
    RP
    Rackliffe PhilipCEO, AIS
    GEHCGE HealthCare Technologies Inc.
    Grant or award
    		A—
    16.5K sh
    		May 15, 2026May 19, 2026
    traded May 15, 2026
    		+4dSEC FORM 4

    Evidence

    36
    YL
    Yang Watkin Phoebe L.Director
    GEHCGE HealthCare Technologies Inc.
    Open-market purchase
    		BUY$63K
    1,000 sh
    		May 8, 2026May 11, 2026
    traded May 8, 2026
    		+3dSEC FORM 4

    Evidence

    25
    Terri A. SewellDSelf
    GEHCGE HealthCare Technologies Inc.
    Sale
    		SELL$1,001 – $15KMar 25, 2026Apr 21, 2026
    traded Mar 25, 2026
    		+27dHOUSE PTR

    Evidence

    25
    Warren DavidsonRSelf
    GEHCGE HealthCare Technologies Inc.
    Sale
    		SELL$1,001 – $15KMar 23, 2026Mar 25, 2026
    traded Mar 23, 2026
    		+2dHOUSE PTR

    Evidence

    9
    RP
    Rackliffe PhilipCEO, AVS
    GEHCGE HealthCare Technologies Inc.
    Grant or award
    		A—
    24.6K sh
    		Mar 2, 2026Mar 4, 2026
    traded Mar 2, 2026
    		+2dSEC FORM 4

    Evidence

    21
    RP
    Rackliffe PhilipCEO, AVS
    GEHCGE HealthCare Technologies Inc.
    Grant or award
    		A—
    9,356 sh
    		Mar 2, 2026Mar 4, 2026
    traded Mar 2, 2026
    		+2dSEC FORM 4

    Evidence

    23
    OM
    O'Neill Kevin MichaelCEO, PDx
    GEHCGE HealthCare Technologies Inc.
    Grant or award
    		A—
    6,938 sh
    		Feb 12, 2026Feb 17, 2026
    traded Feb 12, 2026
    		+5dSEC FORM 4

    Evidence

    25
    KT
    Kass-Hout TahaChief Technology Officer
    GEHCGE HealthCare Technologies Inc.
    Tax withholding
    		F$617K
    7,787 sh
    		Feb 12, 2026Feb 17, 2026
    traded Feb 12, 2026
    		+5dSEC FORM 4

    Evidence

    25
    RR
    Rott RolandCEO, Imaging
    GEHCGE HealthCare Technologies Inc.
    Tax withholding
    		F$312K
    3,943 sh
    		Feb 12, 2026Feb 17, 2026
    traded Feb 12, 2026
    		+5dSEC FORM 4

    Evidence

    25
    OM
    O'Neill Kevin MichaelCEO, PDx
    GEHCGE HealthCare Technologies Inc.
    Tax withholding
    		F$258K
    3,261 sh
    		Feb 12, 2026Feb 17, 2026
    traded Feb 12, 2026
    		+5dSEC FORM 4

    Evidence

    22
    NA
    Newcomb George A.Chief Accounting Officer
    GEHCGE HealthCare Technologies Inc.
    Tax withholding
    		F$64K
    802 sh
    		Feb 12, 2026Feb 17, 2026
    traded Feb 12, 2026
    		+5dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001940538-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    May 7, 2026
    Published
    May 11, 2026
    Ingested by INSIDER
    Nov 5, 03:59 UTC
    Last re-read
    Nov 5, 03:59 UTC

    Extracted facts

    Filer
    Yang Watkin Phoebe L.
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    GE HealthCare Technologies Inc.
    Ticker
    GEHC
    Shares
    3,586
    Price per share
    $0
    Execution date (reported)
    May 7, 2026
    Owned after transaction
    12.7K shares
    Days from execution to publication
    4

    What this establishes

    Yang Watkin Phoebe L. filed this Form 4 reporting a grant or award of GEHC on May 7, 2026. It became public on May 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Yang Watkin Phoebe L.cik:0001940538
    Issuer
    GE HealthCare Technologies Inc.cik:0001932393

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.